Past Meeting | Keystone Symposia

This meeting took place in the past. Here is a list of meetings that are related:
Microbiome: Therapeutic Implications (2020T1)
Microbiome: Chemical Mechanisms and Biological Consequences (2019C3)
Microbiome, Host Resistance and Disease (2018X4)
Manipulation of the Gut Microbiota for Metabolic Health (2018X3)

Web Desc
Microbiome in Health and Disease joint with Inflammation-Driven Cancer: Mechanisms to Therapy Organizer(s): Julie A. Segre, Ramnik Xavier and William Michael Dunne Date: February 05 - 09, 2017 Location: Keystone Resort, Keystone, CO, USA Sponsored by Intercept Pharmaceuticals, Inc., Merck & Co., Inc. and Novartis Institutes for BioMedical Research. Part of the Keystone Symposia Global Health Series, supported by the Bill & Melinda Gates Foundation. For important information on the coronavirus, please click here Summary of Meeting: This Keystone Symposia meeting brings together experts in clinical medicine, clinical microbiology, microbial genomics, and bacterial genetics to explore how both strain variation and underlying microbial community determine health and disease. Genomic advances provide higher-level resolution to both pathogen and host genetic determinants. This meeting aims to explore how monitoring and potentially altering the microbial community may modulate and predict disease risk. Global Health Travel Award Deadline: September 6 2016 Scholarship Deadline: October 6 2016 Discounted Abstract Deadline: October 6 2016 Abstract Deadline: November 3 2016 Discounted Registration Deadline: December 7 2016 Abstract submission is now closed. Registered attendees may bring a poster onsite. Please contact our office at +1 800-253-0685; +1 970-262-1230 or email info@keystonesymposia.org if you are interested. Keystone Symposia thanks our Sponsor(s) for generously supporting this meeting: We gratefully acknowledge additional support for this conference from: We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements: bioMérieux, Inc. We gratefully acknowledge the generous grant for this conference provided by: National Institute of Allergy and Infectious Diseases (NIAID) Grant No. 1R13AI129385-01 The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government. We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising: Click here to view more of these organizations Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds: Click here to view more of these organizations

Web Desc

Microbiome in Health and Disease

joint with Inflammation-Driven Cancer: Mechanisms to Therapy

Organizer(s): Julie A. Segre, Ramnik Xavier and William Michael Dunne

Date: February 05 - 09, 2017
Location: Keystone Resort, Keystone, CO, USA

Sponsored by Intercept Pharmaceuticals, Inc., Merck & Co., Inc. and Novartis Institutes for BioMedical Research. Part of the Keystone Symposia Global Health Series, supported by the Bill & Melinda Gates Foundation.

For important information on the coronavirus, please click here

Summary of Meeting:

This Keystone Symposia meeting brings together experts in clinical medicine, clinical microbiology, microbial genomics, and bacterial genetics to explore how both strain variation and underlying microbial community determine health and disease. Genomic advances provide higher-level resolution to both pathogen and host genetic determinants. This meeting aims to explore how monitoring and potentially altering the microbial community may modulate and predict disease risk.

Global Health Travel Award Deadline: September 6 2016

Scholarship Deadline: October 6 2016

Discounted Abstract Deadline: October 6 2016

Abstract Deadline: November 3 2016

Discounted Registration Deadline: December 7 2016

Abstract submission is now closed. Registered attendees may bring a poster onsite. Please contact our office at +1 800-253-0685; +1 970-262-1230 or email info@keystonesymposia.org if you are interested.

Keystone Symposia thanks our Sponsor(s) for generously supporting this meeting:

We gratefully acknowledge additional support for this conference from:

We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:

bioMérieux, Inc.

We gratefully acknowledge the generous grant for this conference provided by:

National Institute of Allergy and Infectious Diseases (NIAID)
Grant No. 1R13AI129385-01
The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations

Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

Program


Sunday, February 05 \| 4:00PM - 8:00PM Arrival and Registration Room: Longs Peak Foyer
Sunday, February 05 \| 6:00PM - 8:00PM Welcome Mixer Room: Longs Peak Foyer No registration fees are used to fund alcohol served at this function.
Monday, February 06 \| 7:00AM - 8:00AM Breakfast Room: Colorado Rockies Ballroom
Monday, February 06 \| 8:00AM - 9:00AM Welcome and Keynote Address Room: Grays/Longs Peak Speaker 1 of 2 * Julie A. Segre, National Institutes of Health, USA
Monday, February 06 \| 8:00AM - 9:00AM Welcome and Keynote Address Room: Grays/Longs Peak Speaker 2 of 2 Sarkis K. Mazmanian, California Institute of Technology, USA The Gut-Microbiome-Brain Connection in Neurological Diseases
Monday, February 06 \| 9:00AM - 11:15AM Monitoring Microbiome to Predict Disease Risk Room: Grays/Longs Peak Speaker 1 of 5 * William Michael Dunne, bioMérieux, Inc., USA
Monday, February 06 \| 9:00AM - 11:15AM Monitoring Microbiome to Predict Disease Risk Room: Grays/Longs Peak Speaker 2 of 5 Hera Vlamakis, Broad Institute, USA IBD, Crohn’s Microbiome
Monday, February 06 \| 9:00AM - 11:15AM Monitoring Microbiome to Predict Disease Risk Room: Grays/Longs Peak Coffee Break
Monday, February 06 \| 9:00AM - 11:15AM Monitoring Microbiome to Predict Disease Risk Room: Grays/Longs Peak Speaker 4 of 5 Dan R. Littman, HHMI/New York University School of Medicine, USA Regulation of T Cell Responses by Microbiota
Monday, February 06 \| 9:00AM - 11:15AM Monitoring Microbiome to Predict Disease Risk Room: Grays/Longs Peak Speaker 5 of 5 Curtis C. Harris, NCI, National Institutes of Health, USA Microbiome-TP53 Gene Interaction in Human Lung Cancer
Monday, February 06 \| 9:00AM - 11:15AM Inflammation-Driven Cancer This session is from Inflammation-Driven Cancer Room: Quandary Peak Speaker 1 of 6 * Michael Karin, University of California, San Diego, USA
Monday, February 06 \| 9:00AM - 11:15AM Inflammation-Driven Cancer This session is from Inflammation-Driven Cancer Room: Quandary Peak Speaker 2 of 6 Fiona M. Powrie, University of Oxford, UK Inflammation-Driven Cancer: Host and Microbial Pathways
Monday, February 06 \| 9:00AM - 11:15AM Inflammation-Driven Cancer This session is from Inflammation-Driven Cancer Room: Quandary Peak Coffee Break
Monday, February 06 \| 9:00AM - 11:15AM Inflammation-Driven Cancer This session is from Inflammation-Driven Cancer Room: Quandary Peak Speaker 4 of 6 Mathias Florian Heikenwälder, German Cancer Research Center, DKFZ, Germany On the Role of Immune Cells in NASH and NASH to HCC Transition
Monday, February 06 \| 9:00AM - 11:15AM Inflammation-Driven Cancer This session is from Inflammation-Driven Cancer Room: Quandary Peak Speaker 5 of 6 Arthur Kaser, University of Cambridge, UK ER Stress and Colorectal Cancer
Monday, February 06 \| 9:00AM - 11:15AM Inflammation-Driven Cancer This session is from Inflammation-Driven Cancer Room: Quandary Peak Speaker 6 of 6 Jeonghyun Ahn, University of Miami, USA Short Talk: The Role of STING in Suppressing Inflammation-Driven Intestinal Tumorigenesis
Monday, February 06 \| 11:15AM - 12:30PM NIH Institutes’ Interests in Microbiome Research Room: Grays/Longs Peak Speaker 1 of 6 * Robert W. Karp, National Institutes of Health, USA
Monday, February 06 \| 11:15AM - 12:30PM NIH Institutes’ Interests in Microbiome Research Room: Grays/Longs Peak Speaker 2 of 6 Ryan Ranallo, NIAID, National Institutes of Health, USA
Monday, February 06 \| 11:15AM - 12:30PM NIH Institutes’ Interests in Microbiome Research Room: Grays/Longs Peak Speaker 3 of 6 Phil J. Daschner, NCI, National Institutes of Health, USA
Monday, February 06 \| 11:15AM - 12:30PM NIH Institutes’ Interests in Microbiome Research Room: Grays/Longs Peak Speaker 4 of 6 Elisabet Caler, NHLBI, National Institutes of Health, USA
Monday, February 06 \| 11:15AM - 12:30PM NIH Institutes’ Interests in Microbiome Research Room: Grays/Longs Peak Speaker 5 of 6 Ricardo R. Cibotti, NIAMS, National Institutes of Health, USA
Monday, February 06 \| 11:15AM - 12:30PM NIH Institutes’ Interests in Microbiome Research Room: Grays/Longs Peak Speaker 6 of 6 Francesca Macchiarini, NIA, National Institutes of Health, USA
Monday, February 06 \| 11:15AM - 1:00PM Poster Setup Room: Colorado Rockies Ballroom
Monday, February 06 \| 12:30PM - 5:00PM On Own for Lunch
Monday, February 06 \| 1:00PM - 10:00PM Poster Viewing Room: Colorado Rockies Ballroom
Monday, February 06 \| 2:30PM - 4:30PM Workshop 1: Microbiome in Health and Disease Room: Grays/Longs Peak Speaker 1 of 7 * Ami S. Bhatt, Stanford University, USA
Monday, February 06 \| 2:30PM - 4:30PM Workshop 1: Microbiome in Health and Disease Room: Grays/Longs Peak Speaker 2 of 7 Michael C. Abt, Sloan Kettering Institute, USA Host Immune Response Supports Fecal Microbiota Transplant-Mediated Clearance of Clostridium Difficile Infection
Monday, February 06 \| 2:30PM - 4:30PM Workshop 1: Microbiome in Health and Disease Room: Grays/Longs Peak Speaker 3 of 7 Dingding An, Harvard Medical School, USA Microbial Sphingolipids Modulate Host Epithelium Homeostasis and Disease
Monday, February 06 \| 2:30PM - 4:30PM Workshop 1: Microbiome in Health and Disease Room: Grays/Longs Peak Speaker 4 of 7 Naama Geva-Zatorsky, Harvard Medical School, USA Gut Microbiota-Host Interactions and their Immune Modulations
Monday, February 06 \| 2:30PM - 4:30PM Workshop 1: Microbiome in Health and Disease Room: Grays/Longs Peak Speaker 5 of 7 Yun-Gi Kim, Keio University, Japan Neonatal Acquisition of Clostridia Species Controls Colonization Resistance Against Bacterial Pathogens
Monday, February 06 \| 2:30PM - 4:30PM Workshop 1: Microbiome in Health and Disease Room: Grays/Longs Peak Speaker 6 of 7 Monica Viladomiu, Weill Cornell Medicine, USA Functional Characterization of IgA-Targeted E. coli in Crohn's Disease-Associated Spondyloarthritis Links Mucosal Immunity with Systemic Inflammation
Monday, February 06 \| 2:30PM - 4:30PM Workshop 1: Microbiome in Health and Disease Room: Grays/Longs Peak Speaker 7 of 7 Xochitl Morgan, University of Otago, New Zealand Gut Microbiota Acquisition in New Zealand Children in Relation to Early Life Exposures Including Probiotics: A Longitudinal Analysis
Monday, February 06 \| 2:30PM - 4:30PM Workshop 1: Inflammation-Driven Cancer This session is from Inflammation-Driven Cancer Room: Quandary Peak Speaker 1 of 9 * Hua E. Yu, Beckman Research Institute, City of Hope, USA
Monday, February 06 \| 2:30PM - 4:30PM Workshop 1: Inflammation-Driven Cancer This session is from Inflammation-Driven Cancer Room: Quandary Peak Speaker 2 of 9 * Mathias Florian Heikenwälder, German Cancer Research Center, DKFZ, Germany
Monday, February 06 \| 2:30PM - 4:30PM Workshop 1: Inflammation-Driven Cancer This session is from Inflammation-Driven Cancer Room: Quandary Peak Speaker 3 of 9 Ryan Kolb, University of Iowa, USA IL-1beta Promotes Obesity-driven Breast Cancer Progression through the Upregulation of ANGPTL4 in Adipocytes
Monday, February 06 \| 2:30PM - 4:30PM Workshop 1: Inflammation-Driven Cancer This session is from Inflammation-Driven Cancer Room: Quandary Peak Speaker 4 of 9 Sarah McCuaig, University of Oxford, UK Cytokine-Oncogene Synergies in Colorectal Cancer
Monday, February 06 \| 2:30PM - 4:30PM Workshop 1: Inflammation-Driven Cancer This session is from Inflammation-Driven Cancer Room: Quandary Peak Speaker 5 of 9 Seyed Javad Moghaddam, University of Texas MD Anderson Cancer Center, USA Muc5ac Plays an Essential Role in Promotion of K-ras Mutant Lung Cancer by Inflammation
Monday, February 06 \| 2:30PM - 4:30PM Workshop 1: Inflammation-Driven Cancer This session is from Inflammation-Driven Cancer Room: Quandary Peak Speaker 6 of 9 Karen Pickering, Beatson Institute, UK Guanine Nucleotide Exchange Factor Vav1 Promotes Survival in Colorectal Cancer through T-Cell Activation
Monday, February 06 \| 2:30PM - 4:30PM Workshop 1: Inflammation-Driven Cancer This session is from Inflammation-Driven Cancer Room: Quandary Peak Speaker 7 of 9 Na-Young Song, Yonsei University College of Dentistry, South Korea Determining the Signaling Pathway of Epithelial-IKKalpha-Deletion-Mediated Symbiotic Bacterial and Fungal Infection in Carcinogenesis
Monday, February 06 \| 2:30PM - 4:30PM Workshop 1: Inflammation-Driven Cancer This session is from Inflammation-Driven Cancer Room: Quandary Peak Speaker 8 of 9 Chunfeng Qu, Cancer Institute/Hospital, Chinese Academy of Medical Sciences, China Liver Inflammatory Macrophages in Response to Hepatitis B Virus (HBV) Proteins Promote Hepatocellular Carcinoma by Enhancing Angiogenesis through IL23/IL23R Interaction
Monday, February 06 \| 2:30PM - 4:30PM Workshop 1: Inflammation-Driven Cancer This session is from Inflammation-Driven Cancer Room: Quandary Peak Speaker 9 of 9 Martina Seiffert, German Cancer Research Center, Germany Tumor Exosome-Derived Y RNA Activates TLR7/8 Signaling in Monocytes and Contributes to Cancer Inflammation and Immune Escape
Monday, February 06 \| 4:30PM - 5:00PM Coffee Available Room: Longs Peak Foyer
Monday, February 06 \| 5:00PM - 7:15PM Microbiome and Cancer (Joint) Room: Longs/Grays Peak Speaker 1 of 5 * Arthur Kaser, University of Cambridge, UK
Monday, February 06 \| 5:00PM - 7:15PM Microbiome and Cancer (Joint) Room: Longs/Grays Peak Speaker 2 of 5 Laurence Zitvogel, Institut Gustave Roussy, France Microbe-Driven Anti-Tumor Immunity
Monday, February 06 \| 5:00PM - 7:15PM Microbiome and Cancer (Joint) Room: Longs/Grays Peak Speaker 3 of 5 Giorgio Trinchieri, NCI, National Institutes of Health, USA Role of the Microbiota in Inflammation, Carcinogenesis and Cancer Therapy
Monday, February 06 \| 5:00PM - 7:15PM Microbiome and Cancer (Joint) Room: Longs/Grays Peak Speaker 4 of 5 Curtis Huttenhower, Harvard School of Public Health, USA Functional Analysis of Strains in the Human Gut Metatranscriptome
Monday, February 06 \| 5:00PM - 7:15PM Microbiome and Cancer (Joint) Room: Longs/Grays Peak Speaker 5 of 5 Cynthia L. Sears, Johns Hopkins University School of Medicine, USA The carcinogenic potential of bacterial biofilms
Monday, February 06 \| 7:15PM - 8:15PM Social Hour with Lite Bites Room: Colorado Rockies Ballroom No registration fees are used to fund alcohol served at this function.
Monday, February 06 \| 7:30PM - 10:00PM Poster Session 1 Room: Colorado Rockies Ballroom
Tuesday, February 07 \| 7:00AM - 8:00AM Breakfast Room: Colorado Rockies Ballroom
Tuesday, February 07 \| 8:00AM - 11:00AM Complex Microbiome Analyses Room: Grays/Longs Peak Speaker 1 of 7 * Julie A. Segre, National Institutes of Health, USA
Tuesday, February 07 \| 8:00AM - 11:00AM Complex Microbiome Analyses Room: Grays/Longs Peak Speaker 2 of 7 Rob Knight, University of California, San Diego, USA Human Microbiome and Metabolome Dynamics
Tuesday, February 07 \| 8:00AM - 11:00AM Complex Microbiome Analyses Room: Grays/Longs Peak Speaker 3 of 7 Gautam Dantas, Washington University School of Medicine, USA Networks of Exchanging Antibiotic Resistance Between Commensal, Environmental, and Pathogenic Bacteria
Tuesday, February 07 \| 8:00AM - 11:00AM Complex Microbiome Analyses Room: Grays/Longs Peak Coffee Break
Tuesday, February 07 \| 8:00AM - 11:00AM Complex Microbiome Analyses Room: Grays/Longs Peak Speaker 5 of 7 Michael A. Fischbach, Stanford University, USA Small Molecules from the Human Microbiota
Tuesday, February 07 \| 8:00AM - 11:00AM Complex Microbiome Analyses Room: Grays/Longs Peak Speaker 6 of 7 Katherine S. Pollard, University of California, San Francisco, USA Decoding Cryptic Variation in the Human Microbiome
Tuesday, February 07 \| 8:00AM - 11:00AM Complex Microbiome Analyses Room: Grays/Longs Peak Speaker 7 of 7 Kelly Wen Li Chen, Massachusetts Institute of Technology, USA Short Talk: Integrated Gut/Liver Microphysiological System Elucidates Cytokine/Chemokine Inter-Tissue Crosstalk under Endotoxin-Induced Stress
Tuesday, February 07 \| 8:00AM - 11:15AM Inflammation and Cancer Stem Cells This session is from Inflammation-Driven Cancer Room: Quandary Peak Speaker 1 of 8 * Owen J. Sansom, Beatson Institute of Cancer Research, UK
Tuesday, February 07 \| 8:00AM - 11:15AM Inflammation and Cancer Stem Cells This session is from Inflammation-Driven Cancer Room: Quandary Peak Speaker 2 of 8 Matthias Ernst, Olivia Newton-John Cancer Research Institute, Australia Excessive HCK Kinase Activity in the Tumor Stroma Polarizes Macrophages and Promotes Solid Malignancies
Tuesday, February 07 \| 8:00AM - 11:15AM Inflammation and Cancer Stem Cells This session is from Inflammation-Driven Cancer Room: Quandary Peak Speaker 3 of 8 Simon J. Leedham, University of Oxford, UK Morphogen Signaling in Intestinal Inflammation and Carcinogenesis
Tuesday, February 07 \| 8:00AM - 11:15AM Inflammation and Cancer Stem Cells This session is from Inflammation-Driven Cancer Room: Quandary Peak Coffee Break
Tuesday, February 07 \| 8:00AM - 11:15AM Inflammation and Cancer Stem Cells This session is from Inflammation-Driven Cancer Room: Quandary Peak Speaker 5 of 8 Fiona M. Watt, King's College London School of Medicine, UK Contribution of Different Epidermal Cell Populations to Inflammation-Associated Cancers
Tuesday, February 07 \| 8:00AM - 11:15AM Inflammation and Cancer Stem Cells This session is from Inflammation-Driven Cancer Room: Quandary Peak Speaker 6 of 8 Judith A. Varner, University of California, San Diego, USA Targeting Macrophage Signaling to Suppress Tumor Progression
Tuesday, February 07 \| 8:00AM - 11:15AM Inflammation and Cancer Stem Cells This session is from Inflammation-Driven Cancer Room: Quandary Peak Speaker 7 of 8 Min-Kyung Choo, Takeda, USA Short Talk: p38 MAPK Functions as a Tumor Suppressor in Skin Epithelial Cells, but as a Tumor Promoter in Myeloid Cells
Tuesday, February 07 \| 8:00AM - 11:15AM Inflammation and Cancer Stem Cells This session is from Inflammation-Driven Cancer Room: Quandary Peak Speaker 8 of 8 Jelena Todoric, University of California, San Diego, USA Short Talk: A Stress Activated p62-NRF2-MDM2 Axis Drives Pancreatic Tumorigenesis
Tuesday, February 07 \| 11:00AM - 5:00PM On Own for Lunch
Tuesday, February 07 \| 11:00AM - 1:00PM Poster Setup Room: Colorado Rockies Ballroom
Tuesday, February 07 \| 1:00PM - 10:00PM Poster Viewing Room: Colorado Rockies Ballroom
Tuesday, February 07 \| 2:30PM - 4:30PM Panel: The Integrative Human Microbiome Project (iHMP) Room: Grays/Longs Peak The Integrative Human Microbiome Project (iHMP) is the second phase of the National Institute of Health (NIH) Common Fund's Human Microbiome Project (HMP) program. The mission of the overall HMP is to generate resources to permit comprehensive characterization of the human microbiota to further our understanding of how the microbiome impacts human health and disease. In this phase of the program, the iHMP is creating integrated longitudinal datasets of biological properties from both the microbiome and host from three different cohort studies of microbiome-associated conditions using multiple 'omics' technologies. Tools, datasets and other resources from the first phase of the project are available at the HMP DACC. The three iHMP projects have recently completed primary data generation and are entering an initial analysis phase, and this session will detail the data and resources made available to the research community by: 1) the Multi-Omic Microbiome Study: Pregnancy Initiative (MOMS-PI) at Virginia Commonwealth University, 2) the Inflammatory Bowel Disease Multi'omic Data (IBDMDB) resource from the Broad Institute and a nation-wide research tam, and 3) Integrated Personal 'Omics Profiling (IPOP) from Stanford University and the Jackson Laboratory for Genomic Medicine. For more information or to get involved with the iHMP, please see http://hmp2.org. Speaker 1 of 4 * Curtis Huttenhower, Harvard School of Public Health, USA
Tuesday, February 07 \| 2:30PM - 4:30PM Panel: The Integrative Human Microbiome Project (iHMP) Room: Grays/Longs Peak The Integrative Human Microbiome Project (iHMP) is the second phase of the National Institute of Health (NIH) Common Fund's Human Microbiome Project (HMP) program. The mission of the overall HMP is to generate resources to permit comprehensive characterization of the human microbiota to further our understanding of how the microbiome impacts human health and disease. In this phase of the program, the iHMP is creating integrated longitudinal datasets of biological properties from both the microbiome and host from three different cohort studies of microbiome-associated conditions using multiple 'omics' technologies. Tools, datasets and other resources from the first phase of the project are available at the HMP DACC. The three iHMP projects have recently completed primary data generation and are entering an initial analysis phase, and this session will detail the data and resources made available to the research community by: 1) the Multi-Omic Microbiome Study: Pregnancy Initiative (MOMS-PI) at Virginia Commonwealth University, 2) the Inflammatory Bowel Disease Multi'omic Data (IBDMDB) resource from the Broad Institute and a nation-wide research tam, and 3) Integrated Personal 'Omics Profiling (IPOP) from Stanford University and the Jackson Laboratory for Genomic Medicine. For more information or to get involved with the iHMP, please see http://hmp2.org. Speaker 2 of 4 Jennifer M. Fettweis, Virginia Commonwealth University, USA
Tuesday, February 07 \| 2:30PM - 4:30PM Panel: The Integrative Human Microbiome Project (iHMP) Room: Grays/Longs Peak The Integrative Human Microbiome Project (iHMP) is the second phase of the National Institute of Health (NIH) Common Fund's Human Microbiome Project (HMP) program. The mission of the overall HMP is to generate resources to permit comprehensive characterization of the human microbiota to further our understanding of how the microbiome impacts human health and disease. In this phase of the program, the iHMP is creating integrated longitudinal datasets of biological properties from both the microbiome and host from three different cohort studies of microbiome-associated conditions using multiple 'omics' technologies. Tools, datasets and other resources from the first phase of the project are available at the HMP DACC. The three iHMP projects have recently completed primary data generation and are entering an initial analysis phase, and this session will detail the data and resources made available to the research community by: 1) the Multi-Omic Microbiome Study: Pregnancy Initiative (MOMS-PI) at Virginia Commonwealth University, 2) the Inflammatory Bowel Disease Multi'omic Data (IBDMDB) resource from the Broad Institute and a nation-wide research tam, and 3) Integrated Personal 'Omics Profiling (IPOP) from Stanford University and the Jackson Laboratory for Genomic Medicine. For more information or to get involved with the iHMP, please see http://hmp2.org. Speaker 3 of 4 George M. Weinstock, The Jackson Laboratory, USA
Tuesday, February 07 \| 2:30PM - 4:30PM Panel: The Integrative Human Microbiome Project (iHMP) Room: Grays/Longs Peak The Integrative Human Microbiome Project (iHMP) is the second phase of the National Institute of Health (NIH) Common Fund's Human Microbiome Project (HMP) program. The mission of the overall HMP is to generate resources to permit comprehensive characterization of the human microbiota to further our understanding of how the microbiome impacts human health and disease. In this phase of the program, the iHMP is creating integrated longitudinal datasets of biological properties from both the microbiome and host from three different cohort studies of microbiome-associated conditions using multiple 'omics' technologies. Tools, datasets and other resources from the first phase of the project are available at the HMP DACC. The three iHMP projects have recently completed primary data generation and are entering an initial analysis phase, and this session will detail the data and resources made available to the research community by: 1) the Multi-Omic Microbiome Study: Pregnancy Initiative (MOMS-PI) at Virginia Commonwealth University, 2) the Inflammatory Bowel Disease Multi'omic Data (IBDMDB) resource from the Broad Institute and a nation-wide research tam, and 3) Integrated Personal 'Omics Profiling (IPOP) from Stanford University and the Jackson Laboratory for Genomic Medicine. For more information or to get involved with the iHMP, please see http://hmp2.org. Speaker 4 of 4 Anup Mahurkar, University of Maryland Baltimore, USA
Tuesday, February 07 \| 2:30PM - 4:30PM Workshop 2: Inflammation and Immunity Crosstalk This session is from Inflammation-Driven Cancer Room: Quandary Peak Speaker 1 of 9 * Giorgio Trinchieri, NCI, National Institutes of Health, USA
Tuesday, February 07 \| 2:30PM - 4:30PM Workshop 2: Inflammation and Immunity Crosstalk This session is from Inflammation-Driven Cancer Room: Quandary Peak Speaker 2 of 9 * Laurence Zitvogel, Institut Gustave Roussy, France
Tuesday, February 07 \| 2:30PM - 4:30PM Workshop 2: Inflammation and Immunity Crosstalk This session is from Inflammation-Driven Cancer Room: Quandary Peak Speaker 3 of 9 Giuseppe Di Caro, University of California, San Diego, USA Immunoglobulin A Attenuates Colonic Tumorigenesis by Controlling Microbial Translocation and Tumor-Elicited Inflammation
Tuesday, February 07 \| 2:30PM - 4:30PM Workshop 2: Inflammation and Immunity Crosstalk This session is from Inflammation-Driven Cancer Room: Quandary Peak Speaker 4 of 9 Ankit Malik, University of Chicago, USA IL-33 Regulates the IgA-Microbiota Axis to Restrain IL-1alpha Dependent Colitis and Tumorigenesis
Tuesday, February 07 \| 2:30PM - 4:30PM Workshop 2: Inflammation and Immunity Crosstalk This session is from Inflammation-Driven Cancer Room: Quandary Peak Speaker 5 of 9 Andrea Ponzetta, Humanitas Clinical and Research Center, Italy Neutrophils are Protective in Cancerogenesis by Altering Tumor Microenvironment and Controlling Intestinal Microbiota
Tuesday, February 07 \| 2:30PM - 4:30PM Workshop 2: Inflammation and Immunity Crosstalk This session is from Inflammation-Driven Cancer Room: Quandary Peak Speaker 6 of 9 Sabine Waeber, Université de Lausanne, Switzerland Mesenchymal Stem Cells from Human Squamous Cell Lung Carcinoma Modulate Natural Killer (NK) Cell Phenotype and Function
Tuesday, February 07 \| 2:30PM - 4:30PM Workshop 2: Inflammation and Immunity Crosstalk This session is from Inflammation-Driven Cancer Room: Quandary Peak Speaker 7 of 9 Martina Molgora, Humanitas Research Hospital, Italy Interleukin-1 Receptor 8 (IL-1R8) Plays a Crucial Role in Natural Killer Cell Differentiation and Function
Tuesday, February 07 \| 2:30PM - 4:30PM Workshop 2: Inflammation and Immunity Crosstalk This session is from Inflammation-Driven Cancer Room: Quandary Peak Speaker 8 of 9 Venuprasad K. Poojary, Baylor Institute for Immunology Research, USA A Novel Role for Itch in Inhibition of IL-17-Mediated Colon Inflammation and Tumorigenesis by ROR-gammat Ubiquitination
Tuesday, February 07 \| 2:30PM - 4:30PM Workshop 2: Inflammation and Immunity Crosstalk This session is from Inflammation-Driven Cancer Room: Quandary Peak Speaker 9 of 9 Christoph Andreas Reichel, Walter Brendel Centre of Experimental Medicine, Germany Complex Formation of uPA and PAI-1 Promotes Myeloid Leukocyte Trafficking
Tuesday, February 07 \| 4:30PM - 5:00PM Coffee Available Room: Longs Peak Foyer
Tuesday, February 07 \| 5:00PM - 7:00PM Human Microbiome Studies Room: Grays/Longs Peak Speaker 1 of 5 * Robert E.W. Hancock, University of British Columbia, Canada
Tuesday, February 07 \| 5:00PM - 7:00PM Human Microbiome Studies Room: Grays/Longs Peak Speaker 2 of 5 Andrew L. Goodman, Yale School of Medicine, USA Cooperation and Competition in the Human Gut Microbiome
Tuesday, February 07 \| 5:00PM - 7:00PM Human Microbiome Studies Room: Grays/Longs Peak Speaker 3 of 5 Julie A. Segre, National Institutes of Health, USA Human Skin Microbiome: Topographic Functional Mapping of Healthy Volunteers and Patient Populations
Tuesday, February 07 \| 5:00PM - 7:00PM Human Microbiome Studies Room: Grays/Longs Peak Speaker 4 of 5 Gary D. Wu, University of Pennsylvania, USA Diet, the Gut Microbiome and Inflammatory Bowel Disease
Tuesday, February 07 \| 5:00PM - 7:00PM Human Microbiome Studies Room: Grays/Longs Peak Speaker 5 of 5 Renuka Nayak, University of California, San Francisco, USA Short Talk: Methotrexate Is an Antibacterial Drug Metabolized by Human Gut Bacteria
Tuesday, February 07 \| 5:00PM - 7:00PM Tumor-Elicited Inflammation This session is from Inflammation-Driven Cancer Room: Quandary Peak Speaker 1 of 5 * Ming O. Li, Memorial Sloan Kettering Cancer Center, USA
Tuesday, February 07 \| 5:00PM - 7:00PM Tumor-Elicited Inflammation This session is from Inflammation-Driven Cancer Room: Quandary Peak Speaker 2 of 5 Yinling Hu, NCI, National Institutes of Health, USA IKKalpha, Autoimmunity and Chronic Fungal Infection in Esophageal and Skin Carcinogenesis
Tuesday, February 07 \| 5:00PM - 7:00PM Tumor-Elicited Inflammation This session is from Inflammation-Driven Cancer Room: Quandary Peak Speaker 3 of 5 Hua E. Yu, Beckman Research Institute, City of Hope, USA Stat 3 in Cancer Inflammation and as a Target in Cancer
Tuesday, February 07 \| 5:00PM - 7:00PM Tumor-Elicited Inflammation This session is from Inflammation-Driven Cancer Room: Quandary Peak Speaker 4 of 5 Owen J. Sansom, Beatson Institute of Cancer Research, UK Targeting Myeloid Cells in Epithelial Cancers
Tuesday, February 07 \| 5:00PM - 7:00PM Tumor-Elicited Inflammation This session is from Inflammation-Driven Cancer Room: Quandary Peak Speaker 5 of 5 Elena Tosti, Albert Einstein College of Medicine, USA Short Talk: MMR and Tgfb Signaling Cooperate in Suppressing Inflammation-Associated Colorectal Tumorigenesis
Tuesday, February 07 \| 7:00PM - 8:00PM Social Hour with Lite Bites Room: Colorado Rockies Ballroom No registration fees are used to fund alcohol served at this function.
Tuesday, February 07 \| 7:30PM - 10:00PM Poster Session 2 Room: Colorado Rockies Ballroom
Wednesday, February 08 \| 7:00AM - 8:00AM Breakfast Room: Colorado Rockies Ballroom
Wednesday, February 08 \| 8:00AM - 11:00AM Genetic Diversity and Communication Room: Grays/Longs Peak Speaker 1 of 7 * Thaddeus S. Stappenbeck, Cleveland Clinic, USA
Wednesday, February 08 \| 8:00AM - 11:00AM Genetic Diversity and Communication Room: Grays/Longs Peak Speaker 2 of 7 Karen Guillemin, University of Oregon, USA Modulation of Host Innate Immune Responses by Individual Microbiota Members
Wednesday, February 08 \| 8:00AM - 11:00AM Genetic Diversity and Communication Room: Grays/Longs Peak Speaker 3 of 7 Eran Segal, Weizmann Institute of Science, Israel Personalized Nutrition using Gut Microbiome and Clinical Data
Wednesday, February 08 \| 8:00AM - 11:00AM Genetic Diversity and Communication Room: Grays/Longs Peak Coffee Break
Wednesday, February 08 \| 8:00AM - 11:00AM Genetic Diversity and Communication Room: Grays/Longs Peak Speaker 5 of 7 Robert E.W. Hancock, University of British Columbia, Canada Network Biology Approaches to Understanding Inflammation
Wednesday, February 08 \| 8:00AM - 11:00AM Genetic Diversity and Communication Room: Grays/Longs Peak Speaker 6 of 7 James M. Musser, Methodist Hospital Research Institute, USA Integrative Approach to Investigating Human Pathogen-Host Interactions: A Nightmare of Genomic Diversity?
Wednesday, February 08 \| 8:00AM - 11:00AM Genetic Diversity and Communication Room: Grays/Longs Peak Speaker 7 of 7 Mahesh S. Desai, Luxembourg Institute of Health, Luxembourg Short Talk: A Dietary Fiber-Deprived Gut Microbiota Degrades the Colonic Mucus Barrier and Enhances Pathogen Susceptibility
Wednesday, February 08 \| 8:00AM - 11:15AM Inflammation and Immunity Crosstalk I This session is from Inflammation-Driven Cancer Room: Quandary Peak Speaker 1 of 8 * Shannon J. Turley, Genentech, Inc., USA
Wednesday, February 08 \| 8:00AM - 11:15AM Inflammation and Immunity Crosstalk I This session is from Inflammation-Driven Cancer Room: Quandary Peak Speaker 2 of 8 Michael Karin, University of California, San Diego, USA Immune Crosstalk in Tumors
Wednesday, February 08 \| 8:00AM - 11:15AM Inflammation and Immunity Crosstalk I This session is from Inflammation-Driven Cancer Room: Quandary Peak Speaker 3 of 8 Alberto Mantovani, Humanitas University, Italy Innate Immune Pathways and the Tumor Microenvironment
Wednesday, February 08 \| 8:00AM - 11:15AM Inflammation and Immunity Crosstalk I This session is from Inflammation-Driven Cancer Room: Quandary Peak Coffee Break
Wednesday, February 08 \| 8:00AM - 11:15AM Inflammation and Immunity Crosstalk I This session is from Inflammation-Driven Cancer Room: Quandary Peak Speaker 5 of 8 Ming O. Li, Memorial Sloan Kettering Cancer Center, USA Immunity and Tolerance in Cancer
Wednesday, February 08 \| 8:00AM - 11:15AM Inflammation and Immunity Crosstalk I This session is from Inflammation-Driven Cancer Room: Quandary Peak Speaker 6 of 8 Toby Lawrence, INSERM, France Mechanisms of Tumour-Associated Macrophage (TAM) Polarisation
Wednesday, February 08 \| 8:00AM - 11:15AM Inflammation and Immunity Crosstalk I This session is from Inflammation-Driven Cancer Room: Quandary Peak Speaker 7 of 8 Sven Brandau, University Hospital Essen, Germany Short Talk: Absence of Endogenous Toll-Like Receptor Sensing Unleashes Protective Anti-Tumor Immunity and Tumor Regression
Wednesday, February 08 \| 8:00AM - 11:15AM Inflammation and Immunity Crosstalk I This session is from Inflammation-Driven Cancer Room: Quandary Peak Speaker 8 of 8 George Plitas, Memorial Sloan Kettering Cancer Center, USA Short Talk: CD177 Identifies a Novel Subset of Regulatory T Cells (Treg) Infiltrating Human Breast Cancer
Wednesday, February 08 \| 11:00AM - 5:00PM On Own for Lunch
Wednesday, February 08 \| 11:00AM - 1:00PM Poster Setup Room: Colorado Rockies Ballroom
Wednesday, February 08 \| 1:00PM - 10:00PM Poster Viewing Room: Colorado Rockies Ballroom
Wednesday, February 08 \| 4:30PM - 5:00PM Coffee Available Room: Longs Peak Foyer
Wednesday, February 08 \| 5:00PM - 7:00PM Microbiome and Disease Room: Grays/Longs Peak Speaker 1 of 5 * Timothy K. Lu, Massachusetts Institute of Technology, USA
Wednesday, February 08 \| 5:00PM - 7:00PM Microbiome and Disease Room: Grays/Longs Peak Speaker 2 of 5 Thaddeus S. Stappenbeck, Cleveland Clinic, USA Microbial Metabolites that Modify Intestinal Wound Repair
Wednesday, February 08 \| 5:00PM - 7:00PM Microbiome and Disease Room: Grays/Longs Peak Speaker 3 of 5 Kathryn E. Holt, University of Melbourne, Australia Klebsiella Pneumoniae and the Microbiome
Wednesday, February 08 \| 5:00PM - 7:00PM Microbiome and Disease Room: Grays/Longs Peak Speaker 4 of 5 Ami S. Bhatt, Stanford University, USA Metagenomics and the Microbiome in Stem Cell Transplantation
Wednesday, February 08 \| 5:00PM - 7:00PM Microbiome and Disease Room: Grays/Longs Peak Speaker 5 of 5 Lindsay R. Kalan, University of Wisconsin Madison, USA Short Talk: Multi-Kingdom Microbial Communities of Chronic Non-Healing Wounds and their Association with Clinical Outcomes
Wednesday, February 08 \| 5:00PM - 7:00PM Stromal Cells and the Tumor Microenvironment This session is from Inflammation-Driven Cancer Room: Quandary Peak Speaker 1 of 4 * Alberto Mantovani, Humanitas University, Italy
Wednesday, February 08 \| 5:00PM - 7:00PM Stromal Cells and the Tumor Microenvironment This session is from Inflammation-Driven Cancer Room: Quandary Peak Speaker 2 of 4 Shannon J. Turley, Genentech, Inc., USA Leukocyte Function and Positioning in Diverse Stromal Niches
Wednesday, February 08 \| 5:00PM - 7:00PM Stromal Cells and the Tumor Microenvironment This session is from Inflammation-Driven Cancer Room: Quandary Peak Speaker 3 of 4 Daniel L. Worthley, SAHMRI, Adelaide, Australia Intestinal Mesenchyme in the Normal and Neoplastic Colon
Wednesday, February 08 \| 5:00PM - 7:00PM Stromal Cells and the Tumor Microenvironment This session is from Inflammation-Driven Cancer Room: Quandary Peak Speaker 4 of 4 Raghu Kalluri, University of Texas MD Anderson Cancer Center, USA The Functional Role of Inflammation and Fibrosis in Pancreatic Cancer
Wednesday, February 08 \| 7:00PM - 8:00PM Social Hour with Lite Bites Room: Colorado Rockies Ballroom No registration fees are used to fund alcohol served at this function.
Wednesday, February 08 \| 7:30PM - 10:00PM Poster Session 3 Room: Colorado Rockies Ballroom
Thursday, February 09 \| 7:00AM - 8:00AM Breakfast Room: Colorado Rockies Ballroom
Thursday, February 09 \| 8:00AM - 11:00AM Molecular Discovery of Novel Antimicrobials Room: Grays/Longs Peak Speaker 1 of 7 * Sean F. Brady, Rockefeller University, USA
Thursday, February 09 \| 8:00AM - 11:00AM Molecular Discovery of Novel Antimicrobials Room: Grays/Longs Peak Speaker 2 of 7 Andreas Peschel, University of Tübingen, Germany Staphylococcus Aureus in the Human Nose – A Facultative Pathogen's Interference with Microbiota
Thursday, February 09 \| 8:00AM - 11:00AM Molecular Discovery of Novel Antimicrobials Room: Grays/Longs Peak Speaker 3 of 7 William Michael Dunne, bioMérieux, Inc., USA Next-Generation Antimicrobial Susceptibility Testing
Thursday, February 09 \| 8:00AM - 11:00AM Molecular Discovery of Novel Antimicrobials Room: Grays/Longs Peak Coffee Break
Thursday, February 09 \| 8:00AM - 11:00AM Molecular Discovery of Novel Antimicrobials Room: Grays/Longs Peak Speaker 5 of 7 Eric J. Alm, Massachusetts Institute of Technology, USA FMT Complex Analyses
Thursday, February 09 \| 8:00AM - 11:00AM Molecular Discovery of Novel Antimicrobials Room: Grays/Longs Peak Speaker 6 of 7 Silvio M. Vieira, Yale University, USA Short Talk: A Gut Commensal Breaches Both Gut Lymphatic and Vascular Barriers to Drive Systemic Autoimmunity
Thursday, February 09 \| 8:00AM - 11:00AM Molecular Discovery of Novel Antimicrobials Room: Grays/Longs Peak Speaker 7 of 7 Jonathan L. Linehan, NIAID, National Institutes of Health, USA Short Talk: Cutaneous Commensal Bacteria Drive an Unconventional T Cell Response that Accelerates Wound Healing
Thursday, February 09 \| 8:00AM - 11:00AM Inflammation and Immunity Crosstalk II This session is from Inflammation-Driven Cancer Room: Quandary Peak Speaker 1 of 7 * Jane L. Grogan, Arsenal Biosciences, USA
Thursday, February 09 \| 8:00AM - 11:00AM Inflammation and Immunity Crosstalk II This session is from Inflammation-Driven Cancer Room: Quandary Peak Speaker 2 of 7 Weiping Zou, University of Michigan, USA Metabolic Control of Effector T Cells and Regulatory T Cells in Tumor
Thursday, February 09 \| 8:00AM - 11:00AM Inflammation and Immunity Crosstalk II This session is from Inflammation-Driven Cancer Room: Quandary Peak Speaker 3 of 7 Thomas Gajewski, University of Chicago, USA Host Factors Controlling Anti-Tumor Immunity: Unexpected Impact of the Commensal Microbiota
Thursday, February 09 \| 8:00AM - 11:00AM Inflammation and Immunity Crosstalk II This session is from Inflammation-Driven Cancer Room: Quandary Peak Coffee Break
Thursday, February 09 \| 8:00AM - 11:00AM Inflammation and Immunity Crosstalk II This session is from Inflammation-Driven Cancer Room: Quandary Peak Speaker 5 of 7 E. John Wherry, University of Pennsylvania, USA Molecular Basis of T Cell Exhaustion: Insights for Immunotherapy
Thursday, February 09 \| 8:00AM - 11:00AM Inflammation and Immunity Crosstalk II This session is from Inflammation-Driven Cancer Room: Quandary Peak Speaker 6 of 7 Martin Oft, ARMO BioSciences, USA PEGylated IL-10 Induces Th1 and Th2 Immunity, Proliferation of PD1+ Lag-3+ CD8+ T Cells and Multiclonal T Cell Expansion in Cancer Patients
Thursday, February 09 \| 8:00AM - 11:00AM Inflammation and Immunity Crosstalk II This session is from Inflammation-Driven Cancer Room: Quandary Peak Speaker 7 of 7 Bronislaw Pytowski, Eli Lilly, USA Short Talk: The Effect of VEGFR2 Inhibition on Tumor Blood Vessels and Immune Landscape
Thursday, February 09 \| 11:00AM - 5:00PM On Own for Lunch
Thursday, February 09 \| 2:30PM - 4:30PM Workshop 2: Metagenomic Analysis Room: Grays/Longs Peak Speaker 1 of 7 * Eric J. Alm, Massachusetts Institute of Technology, USA
Thursday, February 09 \| 2:30PM - 4:30PM Workshop 2: Metagenomic Analysis Room: Grays/Longs Peak Speaker 2 of 7 Michael G. Constantinides, NIAID, National Institutes of Health, USA Mucosal-Associated Invariant T Cells Respond to Cutaneous Microbiota
Thursday, February 09 \| 2:30PM - 4:30PM Workshop 2: Metagenomic Analysis Room: Grays/Longs Peak Speaker 3 of 7 Collin Edington, Massachusetts Institute of Technology, USA Development of Bioreactor Devices for Microbiome and Multi-Organ Interaction Studies
Thursday, February 09 \| 2:30PM - 4:30PM Workshop 2: Metagenomic Analysis Room: Grays/Longs Peak Speaker 4 of 7 Sho Kitamoto, University of MIchigan Medical School, USA Gut Inflammation-Driven Metabolic Reprograming Regulates the Competitive Fitness of Pathogenic E. coli
Thursday, February 09 \| 2:30PM - 4:30PM Workshop 2: Metagenomic Analysis Room: Grays/Longs Peak Speaker 5 of 7 David T. Riglar, Harvard Medical School, USA Gut Feelings: Engineering Synthetic Bacterial Circuits to Functionally Probe the Mammalian Gut Microbiome
Thursday, February 09 \| 2:30PM - 4:30PM Workshop 2: Metagenomic Analysis Room: Grays/Longs Peak Speaker 6 of 7 Neil Surana, Boston Children’s Hospital, USA Discovery of Disease-Modulating Microbiota Using Microbial Pedigree Analysis
Thursday, February 09 \| 2:30PM - 4:30PM Workshop 2: Metagenomic Analysis Room: Grays/Longs Peak Speaker 7 of 7 Ana Weil, Massachusetts General Hospital, USA The Human Gut Microbiota Predicts Susceptibility to Vibrio cholerae O1 Infection
Thursday, February 09 \| 2:30PM - 4:30PM Workshop 3: Prevention and Therapy This session is from Inflammation-Driven Cancer Room: Quandary Peak Speaker 1 of 8 * Carola H. Ries, Roche Innovation Center Munich, Germany
Thursday, February 09 \| 2:30PM - 4:30PM Workshop 3: Prevention and Therapy This session is from Inflammation-Driven Cancer Room: Quandary Peak Speaker 2 of 8 * E. John Wherry, University of Pennsylvania, USA
Thursday, February 09 \| 2:30PM - 4:30PM Workshop 3: Prevention and Therapy This session is from Inflammation-Driven Cancer Room: Quandary Peak Speaker 3 of 8 Eduardo Bonavita, Cancer Research UK Manchester Institute, University of Manchester, UK COX-2 Expression Positively Associates with Tumor-Promoting Inflammatory Factors and Negatively with Anti-Tumor Immune Pathways in Human Cancer
Thursday, February 09 \| 2:30PM - 4:30PM Workshop 3: Prevention and Therapy This session is from Inflammation-Driven Cancer Room: Quandary Peak Speaker 4 of 8 David N. Brindley, University of Alberta, Canada Blocking the Inflammatory Effects of Lysophosphatidate Signaling as a New Strategy for Decreasing Tumor Growth, Metastasis and Improving Chemotherapy
Thursday, February 09 \| 2:30PM - 4:30PM Workshop 3: Prevention and Therapy This session is from Inflammation-Driven Cancer Room: Quandary Peak Speaker 5 of 8 Feng Zhu, NCI, National Institutes of Health, USA Fungal Infection and Immune Dysfunction Contribute to Esophageal Carcinogenesis
Thursday, February 09 \| 2:30PM - 4:30PM Workshop 3: Prevention and Therapy This session is from Inflammation-Driven Cancer Room: Quandary Peak Speaker 6 of 8 Kayla Knilans, National Institutes of Health, USA Type 2 Signaling Improves Survival and Reduces Tumor Growth in a Mouse Model of Colitis-Associated Cancer
Thursday, February 09 \| 2:30PM - 4:30PM Workshop 3: Prevention and Therapy This session is from Inflammation-Driven Cancer Room: Quandary Peak Speaker 7 of 8 Jeff Kwak, University of Colorado Denver, USA Complement Activation Mediates Lung Cancer Progression and Metastasis through Alterations in CD4 T Lymphocytes
Thursday, February 09 \| 2:30PM - 4:30PM Workshop 3: Prevention and Therapy This session is from Inflammation-Driven Cancer Room: Quandary Peak Speaker 8 of 8 Max D. Wellenstein, Netherlands Cancer Institute, Netherlands Loss of p53 Drives Systemic Neutrophilic Inflammation in Breast Cancer
Thursday, February 09 \| 4:30PM - 5:00PM Coffee Available Room: Longs Peak Foyer
Thursday, February 09 \| 5:00PM - 7:00PM Systems Microbiology Room: Grays/Longs Peak Speaker 1 of 5 * Karen Guillemin, University of Oregon, USA
Thursday, February 09 \| 5:00PM - 7:00PM Systems Microbiology Room: Grays/Longs Peak Speaker 2 of 5 Timothy K. Lu, Massachusetts Institute of Technology, USA Engineering the Microbiome
Thursday, February 09 \| 5:00PM - 7:00PM Systems Microbiology Room: Grays/Longs Peak Speaker 3 of 5 James Amos-Landgraf, University of Missouri, USA Suppression of Tumor Growth using Biofilm Producing Sulfate-reducing Bacteria in a Rat Model of Colon Cancer
Thursday, February 09 \| 5:00PM - 7:00PM Systems Microbiology Room: Grays/Longs Peak Speaker 4 of 5 Sean F. Brady, Rockefeller University, USA Microbial Biosynthetic Diversity
Thursday, February 09 \| 5:00PM - 7:00PM Systems Microbiology Room: Grays/Longs Peak Speaker 5 of 5 Alexandra Zhernakova, University Medical Center Groningen, Netherlands Short Talk: Interaction of Genetics and Food Intake Influences Gut Microbiota Composition
Thursday, February 09 \| 5:00PM - 6:45PM Prevention and Therapy This session is from Inflammation-Driven Cancer Room: Quandary Peak Speaker 1 of 5 * Fiona M. Powrie, University of Oxford, UK
Thursday, February 09 \| 5:00PM - 6:45PM Prevention and Therapy This session is from Inflammation-Driven Cancer Room: Quandary Peak Speaker 2 of 5 Carola H. Ries, Roche Innovation Center Munich, Germany Combining Macrophage Targeting with Cancer Immunotherapies
Thursday, February 09 \| 5:00PM - 6:45PM Prevention and Therapy This session is from Inflammation-Driven Cancer Room: Quandary Peak Speaker 3 of 5 Jane L. Grogan, Arsenal Biosciences, USA The Inhibitory Immunoreceptor TIGIT Limits Anti-Tumor Immunity
Thursday, February 09 \| 5:00PM - 6:45PM Prevention and Therapy This session is from Inflammation-Driven Cancer Room: Quandary Peak Speaker 4 of 5 Jen Morton, Cancer Research UK Beatson Institute, Scotland Short Talk: Myeloid Cells as a Therapeutic Target in Pancreatic Cancer
Thursday, February 09 \| 5:00PM - 6:45PM Prevention and Therapy This session is from Inflammation-Driven Cancer Room: Quandary Peak Speaker 5 of 5 Kristen M. Larsen, University of South Carolina, USA Short Talk: The Role of Interleukin 33/ST2 Axis in Liver Metastasis of Colorectal Cancer
Thursday, February 09 \| 6:45PM - 7:00PM Meeting Wrap-Up: Outcomes and Future Directions (Organizers) This session is from Inflammation-Driven Cancer Room: Quandary Peak
Thursday, February 09 \| 7:00PM - 7:15PM Meeting Wrap-Up: Outcomes and Future Directions Room: Grays/Longs Peak Speaker 1 of 1 * William Michael Dunne, bioMérieux, Inc., USA
Thursday, February 09 \| 7:15PM - 8:15PM Social Hour with Lite Bites Room: Colorado Rockies Ballroom No registration fees are used to fund alcohol served at this function.
Thursday, February 09 \| 8:15PM - 11:00PM Entertainment Room: Colorado Rockies Ballroom Entertainment is not subsidized by conference registration fees nor any U.S. federal government grants. Funding for this expense is provided by other revenue sources.
Thursday, February 09 \| 8:15PM - 11:00PM Cash Bar Room: Colorado Rockies Ballroom
Friday, February 10 \| 10:24AM - 10:24AM Departure *Session Chair †Invited, not yet responded.